96628-67-0

Basic information

• Product Name: 3-[(TERT-BUTOXYCARBONYL)AMINO]ETHYL METHANESULFONATE
• Synonyms: 3-[(TERT-BUTOXYCARBONYL)AMINO]ETHYL METHANESULFONATE;Carbamic acid, [2-[(methylsulfonyl)oxy]ethyl]-, 1,1-dimethylethyl ester
• CAS NO: 96628-67-0
• Molecular Formula: C₈H₁₇NO₅S
• Molecular Weight: 239.29
• Mol File: 96628-67-0.mol
• Article Data: 64

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-[(TERT-BUTOXYCARBONYL)AMINO]ETHYL METHANESULFONATE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[(TERT-BUTOXYCARBONYL)AMINO]ETHYL METHANESULFONATE(96628-67-0)
• EPA Substance Registry System: 3-[(TERT-BUTOXYCARBONYL)AMINO]ETHYL METHANESULFONATE(96628-67-0)

Safety Data

• Hazardous Substances Data: 96628-67-0(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 141-43-5 ethanolamine 
• 124-63-0 methanesulfonyl chloride 
• 57260-73-8 N-BOC-1,2-diaminoethane 
• 26690-80-2 2-(N-tert-butoxycarbonylamino)ethanol 
• 7143-01-3 Methanesulfonic anhydride 
• 66866-43-1 N-(t-butoxycarbonyl)glycyl i-butyl carbonate 
• 4530-20-5 BOC-glycine 
• 305856-92-2 tert-butyl 2-hydroxyethyl carbonate 

Downstream Products

• 117861-38-8 tert-butyl 2-azidoethylcarbamate 
• 849472-99-7 [2-(benzylmethylamino)ethyl]carbamic acid tert-butyl ester 
• 753483-46-4 (2-pyrazolo[4,5-b]pyridin-1-ylethyl)carbamic acid tert-butyl ester 
• 920760-35-6 (2-p-tolylsulfanyl-ethyl)-carbamic acid tert-butyl ester 
• 97308-23-1 N-(tert-butoxycarbonyl)aziridine 
• 130622-07-0 2-tert-butoxycarbonylamino-3-(2-tert-butoxycarbonylamino-ethylsulfanyl)-propionic acid 
• 39684-80-5 2-(tert-butoxycarbonylamino)ethyl bromide 
• 918803-14-2 4-((4-(2-aminoethoxy)phenyl)(cyclohexylidene)methyl)phenol 
• 695183-59-6 1-[2-(N-tert-butoxycarbonylamino)ethyl]-5-(R)-(N₃-benzoylthymin-1-yl)-2-(S)-pipecolic acid methyl ester 
• 208577-84-8 [2-(2-Hydroxy-ethylamino)-ethyl]-carbamic acid tert-butyl ester 
• 919085-52-2 tert-butyl (2-(4-cyanophenoxy)ethyl)carbamate 
• 921596-28-3 tert-butyl (2-phenoxyethyl)carbamate 
• 870194-65-3 tert-butyl (2-(2,4-dichlorophenoxy)ethyl)carbamate 
• 1371567-46-2 tert-butyl (2-(3,5-difluorophenoxy)ethyl)carbamate 

Relevant articles and documents

Spectroscopic characterization of interstrand carbinolamine cross-links formed in the 5′-CpG-3′ sequence by the acrolein-derived γ-OH-1,N2-propano-2′-deoxyguanosine DNA adduct

The interstrand N2,N2-dG DNA cross-linking chemistry of the acrolein-derived γ-OH-1,N2-propanodeoxyguanosine (γ-OH-PdG) adduct in the 5′-CpG-3′ sequence was monitored within a dodecamer duplex by NMR spectroscopy, in situ, using a series of site-specific 13C- and 15N-edited experiments. At equilibrium 40% of the DNA was cross-linked, with the carbinolamine form of the cross-link predominating. The cross-link existed in equilibrium with the non-crosslinked N2-(3-oxo-propyl)-dG aldehyde and its geminal diol hydrate. The ratio of aldehyde/diol increased at higher temperatures. The 1,N2-dG cyclic adduct was not detected. Molecular modeling suggested that the carbinolamine linkage should be capable of maintaining Watson-Crick hydrogen bonding at both of the tandem C-G base pairs. In contrast, dehydration of the carbinolamine cross-link to an imine (Schiff base) cross-link, or cyclization of the latter to form a pyrimidopurinone cross-link, was predicted to require disruption of Watson-Crick hydrogen bonding at one or both of the tandem cross-linked C-G base pairs. When the γ-OH-PdG adduct contained within the 5′-CpG-3′ sequence was instead annealed into duplex DNA opposite T, a mixture of the 1,N2-dG cyclic adduct, the aldehyde, and the diol, but no cross-link, was observed. With this mismatched duplex, reaction with the tetrapeptide KWKK formed DNA-peptide cross-links efficiently. When annealed opposite dA, γ-OH-PdG remained as the 1,N2-dG cyclic adduct although transient epimerization was detected by trapping with the peptide KWKK. The results provide a rationale for the stability of interstrand cross-links formed by acrolein and perhaps other αβ-unsaturated aldehydes. These sequence-specific carbinolamine cross-links are anticipated to interfere with DNA replication and contribute to acrolein-mediated genotoxicity.

THERAPEUTIC COMPOSITION OF CURE-PRO COMPOUNDS FOR TARGETED DEGRADATION OF BET DOMAIN PROTEINS, AND METHODS OF MAKING AND USAGE

The present application is directed to a therapeutic composition, comprising two precursor compounds (monomers) that are suitable for assembly via two or more reversible covalent bonds. The monomers are polyfunctionalized molecules comprising a bioorthogo

MACROCYCLES AND THEIR USE

The present disclosure relates to macrocyclic compounds, pharmaceutical compositions containing macrocyclic compounds, and methods of using macrocyclic compounds to treat disease, such as cancer.

Compound as well as preparation method and application thereof

The invention belongs to the technical field of electrochemical sensors, and relates to a compound as well as a preparation method and application thereof, the compound is 1-(2-((tert-butoxycarbonyl) amino) ethyoxyl)-5-ethyl phenazine-5-onium, and the specific structure is as shown in a formula I. The compound is used as a novel electron mediator, and ethyl phenazine is used as a redox center to transfer electrons generated by enzyme oxidation reaction to an electrode; amino ethyoxyl on a side chain serves as a connection modification center and can be connected with enzyme or the surface of an electrode, so that the conductivity is improved, the oxidation-reduction potential is reduced, and the stability, sensitivity and anti-interference performance of the electrochemical enzyme sensor are improved.